News

MNM Bioscience joins ESMO Breast Cancer 2022

Date
May 3, 2022
No items found.

Breast cancer (BC) constitutes the most common female malignancy and nowadays molecular classification of subtypes is crucial to estimate a patient’s prognosis and administer appropriate treatment. It allows tailoring therapeutic strategy much more precisely than using a standalone IHC status.

To address this problem we have developed the SubType Classifier that combines whole genome sequencing (WGS) data and machine learning algorithms supporting molecular-based breast cancer subtype classification.

At the ESMO Breast Cancer Congress 2022, we present the results that confirm that comprehensive genomic data supports the breast cancer subtype classification, reaviling deeper insights into tumor biology. An increasingly better understanding of the topic of breast cancer brings us closer to achieving better results in treatment and survival rate. If an annual mortality reduction of 2.5% per year occurs worldwide, 2.5 million breast cancer deaths would be avoided between 2020 and 2040*. (*WHO) At MNM – taking part in improving BC treatment outcomes is our main goal. Knowledge-based WGS data analysis and pharmaceuticals trials allows delivering verification of treatment way that could match the best.

MNM Bioscience joins ESMO Breast Cancer 2022
September 15, 2022

You may also like

MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project

We are thrilled to announce that MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project.

MNM's platform ARETE works!

MNM's platform ARETE - a proprietary AI technology designed for cancer genomics has been successfully externally validated by one of our Partners.

Our latest Nature Immunology article has been just released

In the Perspective work-issued today, we highlight the possible genetic background of COVID-19 interindividual variability, ranging from asymptomatic infection to life-threatening disease.

Greetings from ECML PKDD 2022!

Maciej Piernik presented one of our core algorithms at the European Conference on Machine Learning and Principles and Practice of Knowledge Discovery in Databases.